SCPHARMACEUTICALS INC. - COMMON STOCK

scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update

13 نوفمبر 2024 16:01:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024

15 أكتوبر 2024 08:30:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

04 سبتمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update

14 أغسطس 2024 16:01:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Announces Pricing of $50.0 Million Public Offering

12 أغسطس 2024 09:48:52 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Announces Non-Dilutive Financings Totaling Up to $125 Million with Perceptive Advisors

12 أغسطس 2024 06:05:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX Indication in Heart Failure

12 أغسطس 2024 06:04:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Announces Positive Topline Study Results for SCP-111 (Furosemide 80 mg/1 mL) Autoinjector

12 أغسطس 2024 06:02:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

12 أغسطس 2024 06:00:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals to Announce Second Quarter 2024 Financial Results on Wednesday, August 14, 2024

08 أغسطس 2024 16:05:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Announces Filing Acceptance of Supplemental New Drug Application (sNDA) Seeking to Expand FUROSCIX Indication to Include Chronic Kidney Disease

25 يوليو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals to Present at the Jefferies Global Healthcare Conference

29 مايو 2024 16:01:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

14 مايو 2024 16:01:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference

13 مايو 2024 16:05:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024

07 مايو 2024 16:05:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection

24 أبريل 2024 08:00:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

13 مارس 2024 16:01:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024

06 مارس 2024 16:01:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

28 فبراير 2024 16:01:00 بحسب Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update

08 نوفمبر 2023 16:01:00 بحسب Nasdaq GlobeNewswire